Maternus-Kliniken Aktiengesellschaft (MAK.DE)
EUR 1.49
(-2.61%)
EUR 1.49
(-2.61%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -9.26 Million EUR | -95.4% |
| 2022 | -7.84 Million EUR | -293.85% |
| 2021 | 4.04 Million EUR | 847.87% |
| 2020 | -541 Thousand EUR | 87.65% |
| 2019 | -4.38 Million EUR | -253.13% |
| 2018 | 2.86 Million EUR | -54.11% |
| 2017 | 6.23 Million EUR | 7.71% |
| 2016 | 5.78 Million EUR | -28.45% |
| 2015 | 8.08 Million EUR | -74.92% |
| 2014 | 32.25 Million EUR | 919.49% |
| 2013 | -3.93 Million EUR | -405.59% |
| 2012 | 1.28 Million EUR | -74.86% |
| 2011 | 5.12 Million EUR | -33.75% |
| 2010 | 7.73 Million EUR | 11.12% |
| 2009 | 6.95 Million EUR | 381.06% |
| 2008 | -2.47 Million EUR | 41.74% |
| 2007 | -4.25 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 2.16 Million EUR | 0.0% |
| 2023 Q3 | -1.83 Million EUR | -43.01% |
| 2023 Q4 | -1.83 Million EUR | 0.0% |
| 2023 FY | -15.32 Million EUR | -95.4% |
| 2023 Q1 | -2.79 Million EUR | 62.45% |
| 2023 Q2 | -1.28 Million EUR | 54.28% |
| 2022 FY | -7.84 Million EUR | -293.85% |
| 2022 Q2 | -1.7 Million EUR | -79.85% |
| 2022 Q3 | -4.12 Million EUR | -141.88% |
| 2022 Q1 | -948 Thousand EUR | -139.27% |
| 2022 Q4 | -7.45 Million EUR | -80.8% |
| 2021 Q1 | 674.5 Thousand EUR | -62.21% |
| 2021 Q3 | -118.5 Thousand EUR | 25.47% |
| 2021 Q2 | -159 Thousand EUR | -123.57% |
| 2021 Q4 | 2.41 Million EUR | 2137.13% |
| 2021 FY | 4.04 Million EUR | 847.87% |
| 2020 Q1 | -117.5 Thousand EUR | 95.62% |
| 2020 Q2 | -303 Thousand EUR | -157.87% |
| 2020 FY | -541 Thousand EUR | 87.65% |
| 2020 Q3 | 247 Thousand EUR | 181.52% |
| 2020 Q4 | 1.78 Million EUR | 622.67% |
| 2019 Q3 | -2.14 Million EUR | -568.82% |
| 2019 Q2 | 457 Thousand EUR | 1318.67% |
| 2019 Q1 | -37.5 Thousand EUR | 95.36% |
| 2019 FY | -4.38 Million EUR | -253.13% |
| 2019 Q4 | -2.68 Million EUR | -25.23% |
| 2018 Q4 | -808 Thousand EUR | 0.0% |
| 2018 Q2 | 388 Thousand EUR | -52.68% |
| 2018 FY | 2.86 Million EUR | -54.11% |
| 2018 Q1 | 820 Thousand EUR | 19.36% |
| 2018 Q3 | -808 Thousand EUR | -308.25% |
| 2017 Q2 | 999 Thousand EUR | -21.65% |
| 2017 Q3 | 687 Thousand EUR | -31.23% |
| 2017 Q4 | 687 Thousand EUR | 0.0% |
| 2017 Q1 | 1.27 Million EUR | -31.21% |
| 2017 FY | 6.23 Million EUR | 7.71% |
| 2016 Q4 | 1.85 Million EUR | 0.0% |
| 2016 FY | 5.78 Million EUR | -28.45% |
| 2016 Q2 | 1.03 Million EUR | -0.72% |
| 2016 Q3 | 1.85 Million EUR | 79.43% |
| 2016 Q1 | 1.04 Million EUR | -81.11% |
| 2015 Q4 | 5.5 Million EUR | 455.14% |
| 2015 FY | 8.08 Million EUR | -74.92% |
| 2015 Q3 | 992 Thousand EUR | 32.44% |
| 2015 Q2 | 749 Thousand EUR | -10.83% |
| 2015 Q1 | 840 Thousand EUR | -97.11% |
| 2014 Q4 | 29.1 Million EUR | 1412.63% |
| 2014 Q3 | 1.92 Million EUR | 207.84% |
| 2014 Q2 | 625 Thousand EUR | -97.84% |
| 2014 Q1 | 29 Million EUR | 1000.9% |
| 2014 FY | 32.25 Million EUR | 919.49% |
| 2013 Q4 | -3.21 Million EUR | -672.78% |
| 2013 Q3 | 562 Thousand EUR | 198.6% |
| 2013 Q2 | -570 Thousand EUR | 19.61% |
| 2013 Q1 | -709 Thousand EUR | 46.85% |
| 2013 FY | -3.93 Million EUR | -405.59% |
| 2012 Q1 | 495 Thousand EUR | -84.01% |
| 2012 Q2 | 292 Thousand EUR | -41.01% |
| 2012 Q3 | 1.83 Million EUR | 528.77% |
| 2012 FY | 1.28 Million EUR | -74.86% |
| 2012 Q4 | -1.33 Million EUR | -172.66% |
| 2011 Q4 | 3.09 Million EUR | 211.47% |
| 2011 Q3 | 994 Thousand EUR | 111.49% |
| 2011 Q2 | 470 Thousand EUR | -16.52% |
| 2011 FY | 5.12 Million EUR | -33.75% |
| 2011 Q1 | 563 Thousand EUR | -77.79% |
| 2010 FY | 7.73 Million EUR | 11.12% |
| 2010 Q4 | 2.53 Million EUR | 19.18% |
| 2010 Q3 | 2.12 Million EUR | -7.48% |
| 2010 Q2 | 2.29 Million EUR | 193.61% |
| 2010 Q1 | 783 Thousand EUR | 0.0% |
| 2009 FY | 6.95 Million EUR | 381.06% |
| 2008 FY | -2.47 Million EUR | 41.74% |
| 2007 FY | -4.25 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 1.36 Billion EUR | 100.676% |
| Fresenius SE & Co. KGaA | 1.14 Billion EUR | 100.81% |
| LIMES Schlosskliniken AG | 5.02 Million EUR | 284.246% |
| M1 Kliniken AG | 15.69 Million EUR | 158.981% |
| MEDICLIN Aktiengesellschaft | 12.72 Million EUR | 172.789% |
| RHÖN-KLINIKUM Aktiengesellschaft | 40.39 Million EUR | 122.921% |
| VITA 34 AG | -3.12 Million EUR | -196.795% |